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CC BY-NC-ND license (http://creativeMicrodeletion at 22q11.2, a common copy number variation (CNV) noted in neurodevelopmen-
tal disorders, may be associated with cognitive impairment. However, cognitive function in in-
dividuals with microduplication remains unclear. This work presents the genetic, clinical, and
brain structural data of two men out of 335 probands with autistic spectrum disorder (ASD) who
had different CNV dosages at 22q11.2, and comparison with their siblings, 55 ASD probands,
and 73 controls. Both showed severe autistic symptoms, but the proband with microduplication
demonstrated better cognitive functions. Furthermore, different cingulate gyrus volume
changes were noted, indicating that the proband with 22q11.2 microduplication had a
different pattern of cingulate gyrus structure. Our comprehensive characterization of the
behavioral, cognitive, and imaging phenotypes of ASD probands with different CNV dosage
at 22q11.2 contribute to how copy number changes at 22q11.2 mediate the phenotypes in
ASD, and pave the way for future clinical and functional study on these variants.
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Figure 1 (A) The pedigrees of the two probands. (B) The copy number changes of the two probands. The arrows indicate the
positions that were validated by using real-time qPCR, and all the validated positions were located on genes DGCR2, COMT, and
LZTR1. The figures with bars reveal the results of qPCR, demonstrating that fathers (U-802 and U831), mothers (U-803 and U832),
and siblings (U-804 and U-833) did not carry copy number changes at 22q11.2. HN560 and C08-018 were reference controls. (C) Red:
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Dosage difference at 22q11.2 in ASD 579Copy number variation (CNV) contributes to genetic etiol-
1ogy of autism spectrum disorder (ASD). The 22q11.2
deletion syndrome (22q11DS) is due to a microdeletion with
a length of 1.5e3 Mb and is associated with developmental
disorders.2,3 It is the most common human deletion syn-
drome,2,4 with prevalence rates estimated as 1:3000 to
1:6000 in the general population. Up to one-third of the
patients with 22q11.2DS develop psychiatric disorders in
their adulthood, and most of these psychiatric disorders are
schizophrenia and schizoaffective disorder.2,3 Around
14e50% of children with 22q11.2 deletion met the diag-
nostic criteria of ASD,5 suggesting that it plays a role in ASD
pathology.
Probands with schizophrenia or ASD demonstrate cogni-
tive impairment. Patients with 22q11.2DS also show cogni-
tive impairment, with an average full intelligence quotient
(IQ) around 70, which is lower than that in their unaffected
siblings and typically developing (TD) controls.3,6 Micro-
deletion at 22q11.2 may play an important role in the pa-
thology of schizophrenia and autism by affecting cognitive
function. In addition, image studies indicate that the
structure of certain brain regions of patients with
22q11.2DS differ from those without 22q11.2DS, including a
reduction of bilateral cingulate grey matter volumes driven
by a decrease in the anterior cingulate gyrus, as well as a
decreased cortical thickness in the posterior cingulate
cortex.7 Besides, the structural abnormalities in the
cingulate gyrus are closely related to executive function
deficits in normal people, 22q11DS,7 and patients with
schizophrenia,8 but not probands with ASD. Despite well-
described clinical features of 22q11.2DS, few reports have
described 22q11.2 microduplication.9
We recruited 335 probands (mean age  standard devi-
ation, 9.39 4.04 years; 299 male, 89.3%) with a clinical
diagnosis of ASD based on Diagnostic and Statistical Manual
of Mental Disorders, 4th edition (DSM-IV) and confirmed by
the Autism Diagnostic Interview-Revised (ADI-R).10 They
were assessed with the Wechsler Intelligence Scale for
Children-Third Edition (WISC III) for intelligence and Wis-
consin Card Sorting Test (WCST) for set-shifting (cognitive
flexibility). Autistic symptoms were reported by their par-
ents on the Social Communication Questionnaire (SCQ) and
Social Responsiveness Scale (SRS).10 The CNVs of these ASD
probands were analyzed using Affymetrix Genome-Wide
Human SNP Array 6.0 (Affymetrix, Inc., Santa Clara, CA,
USA). The results were validated, and the families of these
probands were analyzed using real-time quantitative poly-
merase chain reaction.
The results showed that U-801 (Asperger’s syndrome)
carried a 2.97-Mb microduplication at chromosome 22q11.2
composed of two segments, 929 kb and 2038 kb in length for
each (nucleotide position: 18.64e21.61 Mb), and another
proband (U-830) diagnosed as autism carrying a 2.09-Mb
microdeletion on 22q11.2 (nucleotide position:ASD with 22q11.2 CNV; Orange: ASD group; Green: Sib of ASD with 2
830; (iv) U-830 sib. L_CACZ left caudal anterior cingulate; L_
L_RACZ left rostral anterior cingulate; qPCRZ quantitative polym
R_ICZ right isthmus cingulate; R_PCZ right posterior cingulate; R19.02e21.61 Mb). Both the CNVs of U-801 and U-830 were
de novo and located at similar loci with 87% overlapping
(w2.59 Mb). The CNVs were not found in their sisters
(Figures 1A and 1B). The current and past ADI-R scores of
the two probands met the cut-point for ASD and demon-
strated higher score in qualitative abnormalities in recip-
rocal social interaction at 4e5 years old, as compared to
the average of 335 probands (20.43 6.12). The two pro-
bands also had higher SCQ scores than the cut-off (15) and
SRS score than Taiwanese norm (Table 1). U-833, sister of U-
830, was diagnosed with pervasive developmental disorder,
not otherwise specified (PDD-NOS) with the ADI-R scores at
4e5 years old and SCQ score below the cut-offs.
U-830 (22q11.2 microdeletion) had epilepsy at 8 months
old and was diagnosed with intellectual disability and
autism at 5 years old. His IQ 55 was lower than 70, the
average IQ of patients with 22q11.2 microdeletion,3,6 with
impaired set-shifting assessed by the WCST (Table 1).
Similar results were found in his sister (U-833) who had
PDD-NOS but did not carry 22q112 microdeletion. Proband
U-801 (22q11.2 microduplication) and his sister had normal
IQ profiles and WCST performance (Table 1). The sister of
U-801 did not differ from the norm in Taiwan on cognitive
and social functions, but the sister of U-830 was impaired in
both.
Brain imaging data were collected for the two probands
with ASD, their sisters, 55 sex- and age-matched probands
ASD, and 73 TD controls by 3T scanner (Siemens Magnetom
Tim Trio, MAGNETOM Trio, A Tim System) with a 32-
channel phased-arrayed head coil at National Taiwan Uni-
versity Hospital, Taipei, Taiwan. The image data was pro-
cessed using Freesurfer (http://surfer.nmr.mgh.harvard.
edu/) to calculate the volumes of cingulate gyrus (CG),
divided into rostral and caudal anterior, isthmus, and pos-
terior parts.
Compared to the matched TD controls, U-830 is gener-
ally comparable to the ASD group, showing an increased
volume of bilateral CG (Figure 1C). U-801, like the ASD
group, also showed increased volumes in the left CG across
rostral and caudal anterior, isthmus, and posterior parts,
which were even more extreme than the average of the
matched ASD group. However, U-801 showed decreased
volumes in the right CG except for rostral anterior cingulate
compared to TD, in contrast to a consistently larger CG in
the ASD group. The sisters of the two probands did not show
significant differences in the CG volumes from the matched
TD controls (Figure 1C, right panel).
This study is believed to be the first to conduct a family
study and to compare the neurocognitive function and brain
structure of two probands with ASD with different doses of
CNVs at chromosome 22q11.2 in Han Chinese. We found
that U-830 (22q11.2 microdeletion), compared to U-801
(22q11.2 microduplication), had lower IQ profiles and
impaired cognitive flexibility assessed by the WCST. The
autistic symptoms were generally comparable except a2q11.2 CNV; Blue: control group. (i) U-801; (ii) U-801 sib; (iii) U-
ICZ left isthmus cingulate; L_PCZ left posterior cingulate;
erase chain reaction; R_CACZ right caudal anterior cingulate;
_RACZ right rostral anterior cingulate.
Table 1 Sample characteristics, autistic symptoms, and executive functions for ASD probands and their siblings.
ASD (U-801) SIB (U-804) ASD (U-830) SIB (U-833) 335 probands (Mean SD)
Age at assessment (y) 13.9 8.6 13.8 15 9.39 4.04
Clinical diagnosis Asperger’s syndrome None Autistic disorder PDD-NOS
Gender Male Female Male Female
Autism Diagnostic Interview-Revised current/most severe at age 4e5 y
Qualitative abnormalities in
reciprocal social interaction
(cut-offZ 10)
11/27 d 11/23 11/16 12.39 5.76/20.43 6.12
Qualitative abnormalities in
communication (cut-
offZ 8)
6/12 d 8/20 6/7 11.48 3.83/14.75 4.32
Restricted, repetitive,
stereotyped patterns of
behaviors (cut-offZ 3)
3/5 d 9/10 2/3 5.43 2.48/6.95 2.47
Social Responsiveness Scale Raw score (t score, mean SD of Taiwan’s norm)
Social communication 46 (94.90, 9.99 8.02) 2 (40.59, 8.85 7.28) 42 (89.91, 9.99 8.02) 24 (62.86, 11 10.11) 37.28 14.13
Stereotyped behaviors/
interests
23 (87.93, 5.78 4.54) 0 (37.49, 4.98 3.98) 21 (83.52, 5.78 4.54) 11 (56.38, 6.67 5.56) 18.88 7.0
Social awareness 24 (62.99, 15.36 6.65) 7 (40.69, 12.9 6.34) 18 (53.97, 15.36 6.65) 13 (49.15, 13.58 6.79) 21.70 4.97
Social emotion 15 (72.56, 6.36 3.83) 0 (35.63, 5.56 3.87) 11 (62.11, 6.36 3.83) 6 (48.52, 6.7 4.73) 11.45 4.55
Total score 108 (88.23, 37.51 18.44) 9 (36.24, 32.29 16.92) 92 (79.55, 37.51 18.44) 54 (57.16, 38.04 22.3) 89.24 25.84
Social Communication Questionnaire
Social interaction subscale 15 3 12 1 10.48 5.61
Repetitive behavior 2 0 9 0 4.92 2.72
Communication subscale 2 0 4 1 3.99 1.96
Total score (cut-off
scoreZ 15)
18 3 24 2 18.24 7.08
IQ (%)
Verbal IQ 120 (91) 127 (96) 70 (2) 89 (23) 95.08 23.79
Performance IQ 112 (79) 93 (31) 48 (< 0.1) 68 (2) 96.74 21.04
Full-scale IQ 117 (87) 112 (79) 55 (0.1) 76 (5) 94.85 22.55
Wisconsin Card Sorting Test (%)a
Total errors 10 (95) 18 (87) 95 (< 1) 76 (2) 44.11 26.61
Perseverative response 5 (97) 6 (93) 62 (1) 43 (3) 27.32 25.29
Perseverative errors 5 (96) 6 (93) 52 (1) 41 (2) 23.51 19.31
Nonperseverative errors 5 (88) 12 (66) 43 (2) 35 (5) 20.60 15.71
Conceptual level responses 61 (88) 73 (91) 3 (< 1) 26 (1) 58.44 23.96
ASDZ autism spectrum disorder; IQZ intelligence quotient; PDD-NOSZ pervasive developmental disorder, not otherwise specified; SDZ standard deviation; SIBZ unaffected siblings.
a Percentile 10%, poor performance; percentile 11e90%, normal range; and percentile 91%, good performance.
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Dosage difference at 22q11.2 in ASD 581higher level of communication deficits and restricted/ste-
reotyped behaviors noted at ages of 4e5 years in U-830
than U-801. His sister (U-833, PDD-NOS) also had lower IQ
(76) and impaired cognitive flexibility. The low IQ of U-830
and U-833 might share similar genetic and environmental
factors. We therefore speculate that the 22q11.2 micro-
deletion may contribute to the intelligent deficit of U-830,
indicating that the microdeletion is not the determinant
genetic factor but a potential modifier for ASD phenotype.
Our data from ASD probands support previous research
on the role of 22q11.2 microdeletion in neurodevelopment
among patients with schizophrenia,11 and in its relation to
impaired IQ and cognitive functions as compared to TD
controls12 or the unaffected siblings.6 Despite the consis-
tent findings in 22q11.2 microdeletion,6,11,12 the cognitive
functions in 22q11.2 microduplication have been much less
reported, without convergent results.9 An animal study
using bacterial artificial chromosome transgenic mice to
produce a 190-kb segmental microduplication including
human TXNRD2, COMT, and ARVCF genes revealed that high
copy numbers might contribute to normal learning and
cognitive function via the influence on developmental
maturation, but not contribute to social function,13
implying that the 22q11.2 microduplication might improve
cognitive function. In line with the animal study, U-801
(22q11.2 microduplication, Asperger’s syndrome) had
greater performance IQ and generally superior performance
on WCST compared to his unaffected sister (U-804) without
22q11.2 microduplication, suggesting that microduplication
is associated with better cognitive performance (Table 1).
Furthermore, there is another proband diagnosed with As-
perger’s syndrome with a small microduplication at
22q11.2, < 0.01% of overlapping with the CNV of U-801.
Similar to U-801, U-728 has better performance in cognitive
functions (IQZ 118 and outstanding WCST performance).
By contrast, U-830 (22q11.2 microdeletion) had the worst
cognitive performance as compared to other study
participants.
The CG, a part of the limbic system, shares numerous
connections with the prefrontal cortex and hippocampus
and is involved in cognition and emotion.14 Cumulative
evidence demonstrates the structural abnormalities of CG
in probands with 22q11.2DS and a similar pattern of deficits
in executive function.7 Our imaging findings revealed a
leftward lateralization in CG in the proband with 22q11.2
microduplication that was not observed in the one with
22q11.2 microdeletion, implying that leftward lateraliza-
tion in CG is a possible endophenotype of 22q11.2 micro-
duplication. Evidence suggests that the anterior CG is
involved in cognitive control,15,16 while the dorsal posterior
CG is shown to influence attentional focus.17 Although our
finding did not replicate Dufour’s report7 that probands
with higher executive function had larger total right grey
matter of CG volume in the 22q11.2DS group, the divergent
pattern in CG structural change in U-801 (22q11.2 micro-
duplication) may give a hint for future research on either
cognitive function in ASD or 22q11.2 microduplication
probands.
Although ASD is reported to occur in probands with
22q11.2 microdeletion, our results and a review article18
both showed that few ASD probands had CNVs at 22q11.2.
In addition, only a few probands with 22q11.2microdeletion met the cut-off point of either the Autism
Diagnostic Observation Schedule or SCQ.19 The recurrent
rate of 22q11.2 microduplication seemed to be lower than
22q11.2 microdeletion. No schizophrenia patient was found
to have 22q11.2 microduplication,20 while 22q11.2 micro-
duplication was associated with autism in several studies
without a consistent description on cognitive and behav-
ioral characteristics.
The strength of this study is the comprehensive evalua-
tion of probands with a different dose of copy numbers at
22q11.2, their siblings, matched ASD patients, and matched
TD controls by using the ADI-R, SRS, SCQ, WISC III, WCST and
magnetic resonance imaging assessments. In contrast to the
majority of reports that probands with 22q11.2 micro-
duplication were reported to have cognitive impairment,
this study reported that an ASD proband with 22q11.2
microduplication had cognitive function in the normal
range and displayed leftward lateralization of CG gray
matter volume. The low incident rate of CNVs at 22q11.2
limited our investigation of the associations between ASD
and 22q11.2 CNV changes. This exploratory study provided
a hint of the possible role of 22q11.2 CNV change in the
pathology of cognitive function in ASD. More clinical and
functional studies with a larger sample size are needed to
draw a firm conclusion of 22q11.2 CNVs in the psychopa-
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